Deep learning to detect acute respiratory distress syndrome on chest radiographs: a retrospective study with external validation.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
06 2021
Historique:
received: 09 11 2020
revised: 06 03 2021
accepted: 11 03 2021
pubmed: 25 4 2021
medline: 29 6 2021
entrez: 24 4 2021
Statut: ppublish

Résumé

Acute respiratory distress syndrome (ARDS) is a common, but under-recognised, critical illness syndrome associated with high mortality. An important factor in its under-recognition is the variability in chest radiograph interpretation for ARDS. We sought to train a deep convolutional neural network (CNN) to detect ARDS findings on chest radiographs. CNNs were pretrained on 595 506 radiographs from two centres to identify common chest findings (eg, opacity and effusion), and then trained on 8072 radiographs annotated for ARDS by multiple physicians using various transfer learning approaches. The best performing CNN was tested on chest radiographs in an internal and external cohort, including a subset reviewed by six physicians, including a chest radiologist and physicians trained in intensive care medicine. Chest radiograph data were acquired from four US hospitals. In an internal test set of 1560 chest radiographs from 455 patients with acute hypoxaemic respiratory failure, a CNN could detect ARDS with an area under the receiver operator characteristics curve (AUROC) of 0·92 (95% CI 0·89-0·94). In the subgroup of 413 images reviewed by at least six physicians, its AUROC was 0·93 (95% CI 0·88-0·96), sensitivity 83·0% (95% CI 74·0-91·1), and specificity 88·3% (95% CI 83·1-92·8). Among images with zero of six ARDS annotations (n=155), the median CNN probability was 11%, with six (4%) assigned a probability above 50%. Among images with six of six ARDS annotations (n=27), the median CNN probability was 91%, with two (7%) assigned a probability below 50%. In an external cohort of 958 chest radiographs from 431 patients with sepsis, the AUROC was 0·88 (95% CI 0·85-0·91). When radiographs annotated as equivocal were excluded, the AUROC was 0·93 (0·92-0·95). A CNN can be trained to achieve expert physician-level performance in ARDS detection on chest radiographs. Further research is needed to evaluate the use of these algorithms to support real-time identification of ARDS patients to ensure fidelity with evidence-based care or to support ongoing ARDS research. National Institutes of Health, Department of Defense, and Department of Veterans Affairs.

Sections du résumé

BACKGROUND
Acute respiratory distress syndrome (ARDS) is a common, but under-recognised, critical illness syndrome associated with high mortality. An important factor in its under-recognition is the variability in chest radiograph interpretation for ARDS. We sought to train a deep convolutional neural network (CNN) to detect ARDS findings on chest radiographs.
METHODS
CNNs were pretrained on 595 506 radiographs from two centres to identify common chest findings (eg, opacity and effusion), and then trained on 8072 radiographs annotated for ARDS by multiple physicians using various transfer learning approaches. The best performing CNN was tested on chest radiographs in an internal and external cohort, including a subset reviewed by six physicians, including a chest radiologist and physicians trained in intensive care medicine. Chest radiograph data were acquired from four US hospitals.
FINDINGS
In an internal test set of 1560 chest radiographs from 455 patients with acute hypoxaemic respiratory failure, a CNN could detect ARDS with an area under the receiver operator characteristics curve (AUROC) of 0·92 (95% CI 0·89-0·94). In the subgroup of 413 images reviewed by at least six physicians, its AUROC was 0·93 (95% CI 0·88-0·96), sensitivity 83·0% (95% CI 74·0-91·1), and specificity 88·3% (95% CI 83·1-92·8). Among images with zero of six ARDS annotations (n=155), the median CNN probability was 11%, with six (4%) assigned a probability above 50%. Among images with six of six ARDS annotations (n=27), the median CNN probability was 91%, with two (7%) assigned a probability below 50%. In an external cohort of 958 chest radiographs from 431 patients with sepsis, the AUROC was 0·88 (95% CI 0·85-0·91). When radiographs annotated as equivocal were excluded, the AUROC was 0·93 (0·92-0·95).
INTERPRETATION
A CNN can be trained to achieve expert physician-level performance in ARDS detection on chest radiographs. Further research is needed to evaluate the use of these algorithms to support real-time identification of ARDS patients to ensure fidelity with evidence-based care or to support ongoing ARDS research.
FUNDING
National Institutes of Health, Department of Defense, and Department of Veterans Affairs.

Identifiants

pubmed: 33893070
pii: S2589-7500(21)00056-X
doi: 10.1016/S2589-7500(21)00056-X
pmc: PMC8182690
mid: NIHMS1708195
pii:
doi:

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e340-e348

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL140482
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137006
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL136687
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL125723
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL155804
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM013325
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137915
Pays : United States
Organisme : NHLBI NIH HHS
ID : L30 HL138779
Pays : United States

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The University of Michigan has filed a US Utility Patent application (number 17/082,145) for the invention, University of Michigan IR number 2020–026, Computer vision technologies for rapid disease detection, which uses software technology to process chest radiographs to detect acute diseases, of which MWS, DT, CEG, and KRW report being coinventors, which is related to work reported in this Article. NJM reports fees paid to her institution by Quantum Leap. Healthcare Consortium, Biomark, Athersys, and The Marcus Foundation for work unrelated to the current Article. All other authors declare no competing interests.

Références

Crit Care. 2017 Jan 20;21(1):12
pubmed: 28107822
JAMA. 2016 Dec 13;316(22):2402-2410
pubmed: 27898976
Radiology. 2020 Apr;295(1):4-15
pubmed: 32068507
Ann Am Thorac Soc. 2019 Apr;16(4):488-495
pubmed: 30521765
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
J Am Med Inform Assoc. 2020 Apr 1;27(4):621-633
pubmed: 32106284
PLoS Med. 2018 Nov 6;15(11):e1002683
pubmed: 30399157
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Radiology. 2019 Jan;290(1):218-228
pubmed: 30251934
Chest. 2018 Feb;153(2):361-367
pubmed: 29248620
Intensive Care Med. 2018 Nov;44(11):1849-1858
pubmed: 30343317
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Crit Care Med. 2016 Aug;44(8):1515-22
pubmed: 27035237
Chest. 2010 Nov;138(5):1054-61
pubmed: 20576730
Sci Data. 2019 Dec 12;6(1):317
pubmed: 31831740
Crit Care Med. 2018 May;46(5):743-748
pubmed: 29438110
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Chest. 2014 Apr;145(4):753-761
pubmed: 24385226
Curr Opin Crit Care. 2017 Feb;23(1):10-17
pubmed: 27922845

Auteurs

Michael W Sjoding (MW)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Center for Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. Electronic address: msjoding@umich.edu.

Daniel Taylor (D)

Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Jonathan Motyka (J)

Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Elizabeth Lee (E)

Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA.

Ivan Co (I)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Dru Claar (D)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Jakob I McSparron (JI)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Sardar Ansari (S)

Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Meeta Prasad Kerlin (MP)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

John P Reilly (JP)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Michael G S Shashaty (MGS)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Brian J Anderson (BJ)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Tiffanie K Jones (TK)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Harrison M Drebin (HM)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Caroline A G Ittner (CAG)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Nuala J Meyer (NJ)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Theodore J Iwashyna (TJ)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; VA Center for Clinic Management Research, Ann Arbor, MI, USA; Institute for Social Research, Ann Arbor, MI, USA.

Kevin R Ward (KR)

Center for Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA.

Christopher E Gillies (CE)

Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Center for Integrative Research in Critical Care; Ann Arbor, MI, USA; Michigan Institute for Data Science, University of Michigan, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH